Group A: They have good evidence to support their claims of benefit in specific scenarios
Serious adverse reactions are rare when injections are administered by a qualified provider following proper clinical evaluation
Wessner B, Strasser EM, Spittler A, Roth E (2003) Effect of single and combined supply of glutamine, glycine, N-acetylcysteine, and R, S-alpha-lipoic acid on glutathione content of myelomonocytic cells
Proinflammatory apoptosis
(Information cited from Peptide Handbook by James B
The GLP-1 fatigue guide and the GLP-1 headache guide provide broader context for these side effects across the entire class of incretin-based therapies, not just tirzepatide specifically